Stock Track | Clover Health Soars After-Hours on New CMO Hire at Healthcare Tech Subsidiary

Stock Track

2024-10-09

Shares of Clover Health Corp (CLOV) surged over 5% in after-hours trading on Monday, following the announcement that its subsidiary Counterpart Health has appointed Dr. David Tsay as its new Chief Medical Officer.

Counterpart Health, Clover's AI-powered physician enablement platform, revealed on Monday that it has named David Tsay M.D., Ph.D as its new CMO. Dr. Tsay brings over two decades of experience in health technology, product development, and clinical innovation from leadership roles at companies like Cue Health, Apple, and New York-Presbyterian hospital.

The addition of Dr. Tsay to Counterpart Health's leadership team is seen as a positive development for Clover Health, which is focused on expanding its healthcare technology offerings and capabilities in value-based care models. Investors appear to be reacting favorably to the news, betting that Tsay's expertise can help drive further innovation and growth at Counterpart Health's AI physician enablement platform.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1152133462"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1152133462\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1152133462?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-09 05:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1152133462","market":"us","top_or_hot":-1,"title":"Stock Track | Clover Health Soars After-Hours on New CMO Hire at Healthcare Tech Subsidiary","media":"Stock Track","content":"<html><body><p>Shares of Clover Health Corp (CLOV) surged over 5% in after-hours trading on Monday, following the announcement that its subsidiary Counterpart Health has appointed Dr. David Tsay as its new Chief Medical Officer.</p>\n<p>Counterpart Health, Clover's AI-powered physician enablement platform, revealed on Monday that it has named David Tsay M.D., Ph.D as its new CMO. Dr. Tsay brings over two decades of experience in health technology, product development, and clinical innovation from leadership roles at companies like Cue Health, Apple, and New York-Presbyterian hospital.</p>\n<p>The addition of Dr. Tsay to Counterpart Health's leadership team is seen as a positive development for Clover Health, which is focused on expanding its healthcare technology offerings and capabilities in value-based care models. Investors appear to be reacting favorably to the news, betting that Tsay's expertise can help drive further innovation and growth at Counterpart Health's AI physician enablement platform.</p></body></html>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Stock Track | Clover Health Soars After-Hours on New CMO Hire at Healthcare Tech Subsidiary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Clover Health Soars After-Hours on New CMO Hire at Healthcare Tech Subsidiary\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2024-10-09 05:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shares of Clover Health Corp (CLOV) surged over 5% in after-hours trading on Monday, following the announcement that its subsidiary Counterpart Health has appointed Dr. David Tsay as its new Chief Medical Officer.</p>\n<p>Counterpart Health, Clover's AI-powered physician enablement platform, revealed on Monday that it has named David Tsay M.D., Ph.D as its new CMO. Dr. Tsay brings over two decades of experience in health technology, product development, and clinical innovation from leadership roles at companies like Cue Health, Apple, and New York-Presbyterian hospital.</p>\n<p>The addition of Dr. Tsay to Counterpart Health's leadership team is seen as a positive development for Clover Health, which is focused on expanding its healthcare technology offerings and capabilities in value-based care models. Investors appear to be reacting favorably to the news, betting that Tsay's expertise can help drive further innovation and growth at Counterpart Health's AI physician enablement platform.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CLOV","symbol_name":"Clover Health Corp","start_time":0,"source_url":"","article_id":"1152133462","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1152133462","pubTimestamp":1728421253,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Clover Health Corp  surged over 5% in after-hours trading on Monday, following the announcement that its subsidiary Counterpart Health has appointed Dr. David Tsay as its new Chief Medical Officer.Counterpart Health, Clover's AI-powered physician enablement platform, revealed on Monday that it has named David Tsay M.D., Ph.D as its new CMO. Dr. Tsay brings over two decades of experience in health technology, product development, and clinical innovation from leadership roles at companie","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CLOV":"Clover Health Corp"},"translate_title":"医疗保健科技子公司聘请新首席营销官后，Clover Health盘后股价飙升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLOV":1},"content_text":"Shares of Clover Health Corp (CLOV) surged over 5% in after-hours trading on Monday, following the announcement that its subsidiary Counterpart Health has appointed Dr. David Tsay as its new Chief Medical Officer.\nCounterpart Health, Clover's AI-powered physician enablement platform, revealed on Monday that it has named David Tsay M.D., Ph.D as its new CMO. Dr. Tsay brings over two decades of experience in health technology, product development, and clinical innovation from leadership roles at companies like Cue Health, Apple, and New York-Presbyterian hospital.\nThe addition of Dr. Tsay to Counterpart Health's leadership team is seen as a positive development for Clover Health, which is focused on expanding its healthcare technology offerings and capabilities in value-based care models. Investors appear to be reacting favorably to the news, betting that Tsay's expertise can help drive further innovation and growth at Counterpart Health's AI physician enablement platform.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1}}}